The study, which will commence enrolling up to four hundred people at six sites nationwide afterwards this year, will randomly assign people with treatment method resistant depression to either the IV or nasal spray form of the drug. Regardless of confined evidence, a trial of low-dose intravenous or subcutaneous ketamine https://lisao147vzc4.kylieblog.com/profile